Trial of 2 Ebola Vaccines’ Effectiveness Is Announced (New York Times)
The first clinical trial of an Ebola vaccine is scheduled to begin in Liberia early February, testing candidate vaccines from Merck and Glaxo Smith Kline.
Guinea’s Health Minister Says Ebola Situation ‘Improving’ (NPR.org)
“We saw people shaking hands,” reports correspondent Ofeibea Quist-Arcton, speaking from Guinea’s capital. But is it a real turn-around?
Smart jewelry that camouflages tech reflects consumer wellness trend (MedCity News)
Fitness or fashion? New smart jewelry makes wearables more attractive for women.
Scientists Work to Contain Modified Organisms to Labs (New York Times)
George Church is at it again. Reporting in Nature, his team has developed a complex safety technique to contain genetically modified bacteria, engineering them to require an amino acid that can only be supplied artificially.
Measles Cases Linked to Disneyland Rise, and Debate Over Vaccinations Intensifies (New York Times)
A CDC report documents an increase in measles cases in California, apparently the result of an anti-vaccination movement in the state. The Atlantic reports further on the “new measles.”
Your blood type might say something about your potential health risks (MedCity News)
How likely are you to have certain types of cancer, memory loss or cardiovascular issues? Your blood could provide a roadmap, researchers say.
On painkillers and thinking about getting pregnant? Better talk to your doctor (Washington Post)
A CDC report suggests steering clear of opioid painkillers such as Vicodin and Oxcycontin, and some prescription cough meds. “They’re deadly, they’re addictive, and they cause birth defects,” said CDC Director Tom Frieden.
Asthma is not more prevalent in the inner city, researchers say (Washington Post)
Childhood asthma has long been associated with urban communities, but research from Johns Hopkins University School of Medicine suggests a different take on the chronic condition.